SUBSCRIBE
SUBSCRIBE

Shattuck Labs

NEWS
Hand holding pencil erasing an employee. Dismissal or bankrumptcy concept. Vector illustration.
Layoffs
Shattuck Labs to Lay Off 40% of Workforce
As it shifts focus to a death receptor 3 (DR3) antagonist antibody, Shattuck Labs is cutting a significant number of employees before the end of the year.
October 1, 2024
 · 
2 min read
 · 
Angela Gabriel
Deals
4 Biotech IPOs this Week: Kronos, Shattuck, Spruce and Aziyo
It’s been a fairly busy week for biotech initial public offerings (IPOs) with four announcing their list pricing. Here’s a look.
October 9, 2020
 · 
4 min read
 · 
Mark Terry
JOBS
IN THE PRESS
Bio NC
Shattuck Labs Added to Russell 2000® and 3000® Indexes
December 18, 2020
 · 
2 min read
Bio NC
Shattuck Labs to Present Virtually at Evercore ISI 3rd Annual HealthCONx Conference
November 25, 2020
 · 
1 min read
Business
Shattuck Labs Reports Third Quarter 2020 Financial Results and Recent Business Highlights
November 13, 2020
 · 
9 min read
Drug Development
Shattuck Labs Announces Preclinical Proof of Concept Study on Gamma Delta T Cell Engager, GADLEN™, Platform at SITC 2020
November 11, 2020
 · 
4 min read
Bio NC
Shattuck Labs to Present Virtually at Cowen 4th Annual IO Next Summit
November 6, 2020
 · 
1 min read
Bio NC
Shattuck Labs to Present Poster on Gamma Delta T Cell Engager, GADLEN™, Platform at the Society for Immunotherapy of Cancer’s (SITC) 35th Anniversary Annual Meeting
November 5, 2020
 · 
1 min read
Bio NC
Shattuck Labs to Present at CD47|Sirpα Summit 2020
October 29, 2020
 · 
1 min read
Bio NC
Shattuck Labs to Present at TIGIT Therapies Digital Summit 2020
October 21, 2020
 · 
1 min read
Deals
Shattuck Labs Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
October 14, 2020
 · 
2 min read
Deals
Shattuck Labs Announces Pricing of Upsized Initial Public Offering
October 8, 2020
 · 
3 min read
Load More